ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,222.68
0.16%
US Tech 100
17,650.00
0.05%
다우존스 지수
39,512.84
0.32%
Bitcoin
60,901.86
0.18%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Avalon Pharmaceuticals (MM) (AVRX)

  7. Avalon Pharmaceuticals (MM) (AVRX) 뉴스

AVRX

Avalon (AVRX)

Avalon Pharmaceuticals (MM)
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:AVRX
일자시간출처헤드라인심볼기업
2009/05/1404:39Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
2009/05/0705:48Edgar (US Regulatory)Current report filing (8-K)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
2009/05/0705:46Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
2009/04/2906:05Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
2009/04/2905:49Business WireAvalon Pharmaceuticals Announces Special Meeting DateNASDAQ:AVRXAvalon Pharmaceuticals (MM)
2009/04/0804:00Business WireAvalon Pharmaceuticals Receives Audit Opinion Containing Going Concern StatementNASDAQ:AVRXAvalon Pharmaceuticals (MM)
2009/04/0223:24Edgar (US Regulatory)Current report filing (8-K)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
2009/04/0223:22Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
2009/04/0105:02Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
2009/03/1806:07Edgar (US Regulatory)Current report filing (8-K)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
2009/03/1806:05Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
2009/03/1804:00Business WireAvalon Pharmaceuticals Receives Staff Determination Regarding Nasdaq DelistingNASDAQ:AVRXAvalon Pharmaceuticals (MM)
2009/03/1105:07Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
2009/02/1807:22Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
2009/02/1801:35Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
2009/02/1405:10Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
2009/02/1404:29Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
2009/02/1206:11Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
2009/02/1107:04Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
2009/01/3106:29Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
2009/01/2206:19Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
2009/01/1501:56Edgar (US Regulatory)Current report filing (8-K)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
2009/01/1501:54Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
2008/12/2306:58Edgar (US Regulatory)Current report filing (8-K)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
2008/12/2306:56Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
2008/12/2306:23Business WireAvalon Pharmaceuticals Receives Extension of Time to Comply with NASDAQ Deficiency NoticeNASDAQ:AVRXAvalon Pharmaceuticals (MM)
2008/11/2606:06Edgar (US Regulatory)Current report filing (8-K)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
2008/11/2604:18Business WireAvalon Pharmaceuticals Receives NASDAQ Deficiency NoticeNASDAQ:AVRXAvalon Pharmaceuticals (MM)
2008/11/1402:04Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
2008/11/1103:39Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
 검색 관련기사 보기:NASDAQ:AVRX

최근 히스토리

NYSE
JPM
JP Morgan Chase
NASDAQ
TSLA
Tesla
COIN
ETHUSD
Ethereum
USOTC
DTEGY
Deutsche Telekom (QX)
FX
USDEUR
US Dollar vs Euro
NYSE
MCD
McDonalds
USOTC
RHHBY
Roche (QX)
NYSE
AXP
American Express
FX
USDJPY
US Dollar vs Yen
CCOM
US100
US Tech 100
USOTC
BNPQY
BNP Paribas (QX)
AMEX
XLE
Energy Select Sector SPDR
FX
USDGBP
US Dollar vs Sterling
NYSE
XOM
Exxon Mobil
CCOM
US500
US 500
NYSE
KO
Coca Cola
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유